Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Grayscale Ethereum Mini Trust ETF approval and seeding through Ether distribution
We advised Grayscale on the novel seeding structure akin to a corporate spinoff, and SEC approval for the NYSE Arca listing
QXO $620 million private placement
The shares are traded on Nasdaq
Plug Power $200 million stock offering
The shares are traded on Nasdaq
Clariane €92 million reserved capital increase and €237 million rights offering
We advised Clariane on its refinancing transactions
OSI Systems $350 million convertible senior notes offering
The 2.25% convertible senior notes are due 2029
Morgan Stanley Bank $2.5 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
Morgan Stanley $5.5 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
TWFG $187 million IPO
The shares are listed on the Nasdaq Global Select Market
Banco Santander $3.75 billion notes offering
We advised Banco Santander on its offering of notes
Cleveland-Cliffs $2.5 billion acquisition of Stelco Holdings
We are advising Cleveland-Cliffs on the acquisition